Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)SMITH-SØRENSEN, B; HOVIG, E; ANDERSSON, B et al.Mutation research. 1992, Vol 269, Num 1, pp 41-53, issn 0027-5107Article

Interleukin-1α and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPLANDERSEN, K; MAELANDSMO, G. M; HOVIG, E et al.Anticancer research. 1998, Vol 18, Num 5A, pp 3299-3303, issn 0250-7005Article

Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanomaMAELANDSMO, G. M; FLØRENES, V. A; MELLINGSAETER, T et al.International journal of cancer. 1997, Vol 74, Num 4, pp 464-469, issn 0020-7136Article

Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cellsRUUD, P; FODSTAD, Ø; HOVIG, E et al.International journal of cancer. 1999, Vol 80, Num 1, pp 119-125, issn 0020-7136Article

Connectivity can be used to identify key genes in DNA microarray data : a study based on gene expression in nasal polyps before and after treatment with glucocorticoidsBENSON, M; STEENHOFF HOV, D. A; CLANCY, T et al.Acta oto-laryngologica. 2007, Vol 127, Num 10, pp 1074-1079, issn 0001-6489, 6 p.Article

Interferon-γ suppresses S100A4 transcription independently of apoptosis or cell cycle arrestANDERSEN, K; SMITH-SØRENSEN, B; PEDERSEN, K. B et al.British journal of cancer. 2003, Vol 88, Num 12, pp 1995-2001, issn 0007-0920, 7 p.Article

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutationsBORG, A; DØRUM, A; HEIMDAL, K et al.Disease markers. 1999, Vol 15, Num 1-3, pp 79-84, issn 0278-0240Article

Detection of base mutations in genomic DNA using denaturing gradient gel electrophoresis (DGGE) followed by transfer and hybridization with gene-specific probesBØRRESEN, A.-L; HOVIG, E; BRØGGER, A et al.Mutation research. 1988, Vol 202, Num 1, pp 77-83, issn 0027-5107Article

Genetic epidemiology of BRCA1 mutations in NorwayMØLLER, P; HEIMDAL, K; APOLD, J et al.European journal of cancer (1990). 2001, Vol 37, Num 18, pp 2428-2434, issn 0959-8049Article

Disentangling the perturbational effects of amino acid substitutions in the DNA-binding domain of p53WACEY, A. I; COOPER, D. N; LINEY, D et al.Human genetics. 1999, Vol 104, Num 1, pp 15-22, issn 0340-6717Article

Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozymeMAELANDSMO, G. M; HOVIG, E; SKREDE, M et al.Cancer research (Baltimore). 1996, Vol 56, Num 23, pp 5490-5498, issn 0008-5472Article

Genome scanning of human breast carcinomas using micro- and minisatellite core probesHOVIG, E; MULLAART, E; BØRRESEN, A.-L et al.Genomics (San Diego, Calif.). 1993, Vol 17, Num 1, pp 66-75, issn 0888-7543Article

Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionHOVIG, E; SMITH-SOÊRENSEN, B; BROÊGGER, A et al.Mutation research. Mutation research letters. 1991, Vol 262, Num 1, pp 63-71, issn 0165-7992, 9 p.Article

Expression of a novel factor in human breast cancer cells with metastatic potentialREE, A. H; TVERMYR, M; ENGEBRAATEN, O et al.Cancer research (Baltimore). 1999, Vol 59, Num 18, pp 4675-4680, issn 0008-5472Article

S100A4 involvement in metastasis : Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozymeBJØRNLAND, K; WINBERG, J. O; ØDEGAARD, O. T et al.Cancer research (Baltimore). 1999, Vol 59, Num 18, pp 4702-4708, issn 0008-5472Article

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas : relationship to amplification and mRNA levels of CKD4 and CCND1MAELANDSMO, G. M; BERNER, J.-M; FLØRENCE, V. A et al.British journal of cancer. 1995, Vol 72, Num 2, pp 393-398, issn 0007-0920Article

Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas : a colorimetric approachDEGGERDAL, A. H; PETTERSEN, F; KVALHEIM, G et al.Laboratory investigation. 1995, Vol 72, Num 4, pp 411-418, issn 0023-6837Article

Screening for germ line TP53 mutations in breast cancer patientsBØRRESEN, A.-L; ANDERSEN, T. I; FRIEND, S. H et al.Cancer research (Baltimore). 1992, Vol 52, Num 11, pp 3234-3236, issn 0008-5472Article

A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomasHOVIG, E; ANDREASSEN, A; FANGAN, B. M et al.Cancer genetics and cytogenetics. 1992, Vol 64, Num 2, pp 178-182, issn 0165-4608Article

Increased expression of IRF4 and ETS1 in CD4⁺ cells from patients with intermittent allergic rhinitisBRUHN, S; BARRENÄS, F; WANG, H et al.Allergy (Copenhagen). 2012, Vol 67, Num 1, pp 33-40, issn 0105-4538, 8 p.Article

Associations between gene expressions in breast cancer and patient survivalJENSSEN, T.-K; KUO, W. P; STOKKE, T et al.Human genetics. 2002, Vol 111, Num 4-5, pp 411-420, issn 0340-6717Article

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective seriesMØLLER, P; BORG, A; HEIMDAL, K et al.European journal of cancer (1990). 2001, Vol 37, Num 8, pp 1027-1032, issn 0959-8049Article

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancerDØRUM, A; HEIMDAL, K; HOVIG, E et al.American journal of human genetics. 1999, Vol 65, Num 3, pp 671-679, issn 0002-9297Article

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insADØRUM, A; HOVIG, E; TROPE, C et al.European journal of cancer (1990). 1999, Vol 35, Num 5, pp 779-781, issn 0959-8049Article

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testingDØRUM, A; MØLLER, P; VAN DER MEULEN, M. A et al.European journal of cancer (1990). 1997, Vol 33, Num 14, pp 2390-2392, issn 0959-8049Article